Is Semaglutide Safe After Gallbladder Surgery
Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes
Acknowledgement The author wishes to thank Daniel Soares Freire, MD, PhD for providing medical writing and editorial assistance on behalf of Springer Healthcare
CagriSema (Novo Nordisk) combines an amylin analog with semaglutide and showed about 22.7% weight loss in Phase 3, with a new drug application reportedly submitted
doi: 10.1002/jcla.22929 72 MikulskaAAKaraniewicz-adaMFilipowiczDRuchaaMGwkaFK
What to Expect in Months 4-6 Minimal side effects: 85%+ patients report little to no symptoms Fastest weight loss period: Average loss 15-18% by week 24 Appetite suppression as primary effect: Not unpleasant, just not hungry Metabolic improvements: Blood pressure drops, triglycerides down 28%, A1C down 1.8% in diabetics Increased confidence and motivation: Visible results, compliments from others, clothes fitting differently Data from Diabetes Care journal shows this acceleration phase is when cardiovascular benefits become measurable, blood pressure improvements, lipid improvements, reduced inflammation markers
